Open access · OA
via OpenAlex
Melatonin and inflammation—Story of a double‐edged blade
Journal of Pineal Research · 2018 · ▲ 455 citations
Deregulated nutrient-sensing
Altered intercellular communication
Chronic inflammation
Rapamycin / mTOR inhibition
Cell culture / in vitro
Abstract
Melatonin is an immune modulator that displays both pro- and anti-inflammatory properties. Proinflammatory actions, which are well documented by many studies in isolated cells or leukocyte-derived cell lines, can be assumed to enhance the resistance against pathogens. However, they can be detrimental in autoimmune diseases. Anti-inflammatory actions are of particular medicinal interest, because they are observed in high-grade inflammation such as sepsis, ischemia/reperfusion, and brain injury, and also in low-grade inflammation during aging and in neurodegenerative diseases. The mechanisms contributing to anti-inflammatory effects are manifold and comprise various pathways of secondary signaling. These include numerous antioxidant effects, downregulation of inducible and inhibition of neuronal NO synthases, downregulation of cyclooxygenase-2, inhibition of high-mobility group box-1 signaling and toll-like receptor-4 activation, prevention of inflammasome NLRP3 activation, inhibition of NF-κB activation and upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2). These effects are also reflected by downregulation of proinflammatory and upregulation of anti-inflammatory cytokines. Proinflammatory actions of amyloid-β peptides are reduced by enhancing α-secretase and inhibition of β- and γ-secretases. A particular role in melatonin's actions seems to be associated with the upregulation of sirtuin-1 (SIRT1), which shares various effects known from melatonin and additionally interferes with the signaling by the mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) and Notch, and reduces the expression of the proinflammatory lncRNA-CCL2. The conclusion on a partial mediation by SIRT1 is supported by repeatedly observed inhibitions of melatonin effects by sirtuin inhibitors or knockdown.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jpi.12525
- Canonical
- link ↗
- Fetched
- 2026-10-02 MST
Cite this
APA
Hardeland, R. (2018). Melatonin and inflammation—Story of a double‐edged blade. <em>Journal of Pineal Research</em>. https://doi.org/10.1111/jpi.12525
Vancouver
Hardeland R. Melatonin and inflammation—Story of a double‐edged blade. Journal of Pineal Research. 2018. doi:10.1111/jpi.12525.
BibTeX
@article{rdiger2018Melato,
title = {Melatonin and inflammation—Story of a double‐edged blade},
author = {Rüdiger Hardeland},
journal = {Journal of Pineal Research},
year = {2018},
doi = {10.1111/jpi.12525},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2019
Open access · CC-BY
Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks
Ageing Research Reviews 2022
Open access · CC-BY
Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process
BBA Advances 2022
Open access · CC-BY
mTOR/α-ketoglutarate-mediated signaling pathways in the context of brain neurodegeneration and neuroprotection
Cells 2026
Open access · OA
Bone Aging and Glycative Stress: Convergent and Divergent Mechanisms Driving Skeletal Deterioration.
International Journal of Molecular Sciences 2014
Open access · CC-BY
Melatonin Regulates Aging and Neurodegeneration through Energy Metabolism, Epigenetics, Autophagy and Circadian Rhythm Pathways
Oxidative Medicine and Cellular Longevity 2015
Open access · CC-BY